Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Notizie Vai al feed delle notizie
IVF HARTMANN: half-year revenue and profit rose sharply
IVF HARTMANN increased revenue in the first half of 2026 by 11.3% to CHF 85.9 million. EBIT grew by 27.5% to CHF 12.1 million (margin 14.0%) and net profit rose by 24.7% to CHF 10.3 million, driven by new customers, temporary demand, innovative products, customer-specific services and digital solutions. A revenue increase is still expected for the full year, although growth in the second half is likely to be weaker; the EBIT forecast has been raised to a level above the previous year. The company cites as risks possible margin-pressure effects from falling prices relative to higher-valued inventories and long procurement processes in tactical operational medicine. » Altro su finanzen.net
Claus Martini steps down as CEO of IVF Hartmann after ten years
Claus Martini has resigned as CEO of IVF Hartmann after ten years at the helm. Further details about the resignation and succession were not given in the brief notice. » Altro su finanzen.net
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 93.06m | - |
| Utile lordo | 30.01m | - |
| Utile netto | 11.13m | - |
| EBITDA | 15.50m | - |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 344.01m€ |
Numero di azioni | 2.40m |
Massimo/minimo a 52 settimane | 143,62€ - 112,12€ |
Rendimento da dividendo | 2,91% |
Dividendi TTM | 4,14€ |
Beta | 0,23 |
Rapporto P/E | 15,28 |
Rapporto PEG | 2,35 |
Rapporto P/B | 1,98 |
Rapporto P/S | 1,82 |
Profilo aziendale
Die IVF Hartmann Holding AG vertreibt medizinische Verbrauchsgüter in der Schweiz und international. Das Unternehmen bietet chirurgische Einweginstrumente, Decken, Kleidung und Handschuhe, Desinfektions- und Hygieneprodukte, Dienstleistungen für Wundmanagement und Hydrotherapie, Inkontinenzmanagement und Erste-Hilfe-Produkte sowie verschiedene Kurse an. Das Unternehmen beliefert niedergelassene Ärzte, die ambulante Medizin und Pflege, Krankenhäuser und Kliniken, Apotheken und Drogerien, Pflegeheime, den Medizin- und Lebensmitteleinzelhandel sowie Industriekunden. Das Unternehmen war früher unter dem Namen IVF bekannt und änderte 1993 seinen Namen in IVF Hartmann Holding AG. Das Unternehmen wurde 1874 gegründet und hat seinen Hauptsitz in Neuhausen am Rheinfall, Schweiz.
| Nome | IVF Hartmann |
| CEO | Martin Walther |
| Sede centrale | Neuhausen am Rheinfall,
sh Svizzera |
| Sito web | |
| Quotazione in borsa | 14/04/1995 |
| Dipendenti | 316 |
Deep Dive
Simboli di borsa
| Borsa | Simbolo |
|---|---|
SIX | VBSN.SW |
London Stock Exchange | 0QQM.L |
London | 0QQM.L |
Scopri gli asset
Gli azionisti di IVF Hartmann investono anche nei seguenti asset





